COVID-19 in patients with rheumatic diseases: what is the real mortality risk?
- PMID: 32660978
- DOI: 10.1136/annrheumdis-2020-218388
COVID-19 in patients with rheumatic diseases: what is the real mortality risk?
Keywords: autoimmune diseases; glucocorticoids; lupus erythematosus, systemic.
Conflict of interest statement
Competing interests: None declared.
Comment in
-
Response to: 'COVID-19 in patients with rheumatic diseases: what is the real mortality risk?' by Marques et al.Ann Rheum Dis. 2022 Aug;81(8):e135. doi: 10.1136/annrheumdis-2020-218431. Epub 2020 Jul 13. Ann Rheum Dis. 2022. PMID: 32660976 No abstract available.
Comment on
-
Clinical characteristics and outcomes of patients with coronavirus disease 2019 (COVID-19) and rheumatic disease: a comparative cohort study from a US 'hot spot'.Ann Rheum Dis. 2020 Sep;79(9):1156-1162. doi: 10.1136/annrheumdis-2020-217888. Epub 2020 May 26. Ann Rheum Dis. 2020. PMID: 32457048 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical